BlackRock, Inc.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 2012383 New York, NY

Position in FULC

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$32,296,784

-$9,049,060 QoQ

Shares Held

8,824,259

+63.7% QoQ

Ownership

11.6%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 154 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 94% Shared 0% None 6%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. FULC ranks #195 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,296,784	8,824,259	+63.7%	Shares	Sole	2026-08-07
2026-06-30	$17,578,540	4,802,880	—	Shares	Sole	2026-07-28
2026-03-31	$41,345,844	5,390,593	+26.4%	Shares	Sole	2026-05-13
2025-12-31	$48,223,132	4,263,761	+15.0%	Shares	Sole	2026-02-12
2025-09-30	$34,102,097	3,706,750	-15.4%	Shares	Sole	2025-11-12
2025-06-30	$30,127,676	4,379,023	-7.0%	Shares	Sole	2025-08-12
2025-03-31	$13,566,802	4,710,697	-8.9%	Shares	Sole	2025-05-02
2024-12-31	$24,296,312	5,169,429	-9.4%	Shares	Sole	2025-02-07
2024-09-30	$20,372,298	5,706,527	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.